Prothena Corporation plc

NasdaqGS:PRTA Stock Report

Market Cap: US$895.4m

Prothena Management

Management criteria checks 2/4

Prothena's CEO is Gene Kinney, appointed in Sep 2016, has a tenure of 8.17 years. total yearly compensation is $7.04M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth $213.03K. The average tenure of the management team and the board of directors is 7.7 years and 5.1 years respectively.

Key information

Gene Kinney

Chief executive officer

US$7.0m

Total compensation

CEO salary percentage9.0%
CEO tenure8.2yrs
CEO ownership0.02%
Management average tenure7.7yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)

Oct 18

Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Oct 02
Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Jul 26
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Jun 19
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials

Jun 07

New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

May 14
New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)

Prothena: Alzheimer's Data Update In 2024 Could Move The Needle

Feb 23

Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Feb 08
Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%

Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Dec 20
Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?

Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Nov 24
Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business

Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Oct 27
Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk

Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

Aug 25
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth

What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

May 10
What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Apr 23
We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

Mar 01
Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Dec 28
We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

Prothena: Paying A Premium To Cover All The Alzheimer's Bases

Sep 29

Prothena GAAP EPS of -$0.88 misses by $0.31

Aug 08

Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

May 08
Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates

CEO Compensation Analysis

How has Gene Kinney's remuneration changed compared to Prothena's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$51m

Mar 31 2024n/an/a

-US$172m

Dec 31 2023US$7mUS$631k

-US$147m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$141m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$7mUS$601k

-US$117m

Sep 30 2022n/an/a

-US$156m

Jun 30 2022n/an/a

-US$1m

Mar 31 2022n/an/a

US$67m

Dec 31 2021US$5mUS$573k

US$67m

Sep 30 2021n/an/a

US$69m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$124m

Dec 31 2020US$3mUS$554k

-US$111m

Sep 30 2020n/an/a

-US$102m

Jun 30 2020n/an/a

-US$91m

Mar 31 2020n/an/a

-US$80m

Dec 31 2019US$3mUS$538k

-US$78m

Sep 30 2019n/an/a

-US$79m

Jun 30 2019n/an/a

-US$84m

Mar 31 2019n/an/a

-US$128m

Dec 31 2018US$11mUS$525k

-US$156m

Sep 30 2018n/an/a

-US$181m

Jun 30 2018n/an/a

-US$209m

Mar 31 2018n/an/a

-US$167m

Dec 31 2017US$5mUS$521k

-US$153m

Compensation vs Market: Gene's total compensation ($USD7.04M) is above average for companies of similar size in the US market ($USD3.24M).

Compensation vs Earnings: Gene's compensation has increased whilst the company is unprofitable.


CEO

Gene Kinney (55 yo)

8.2yrs

Tenure

US$7,043,826

Compensation

Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...


Leadership Team

NamePositionTenureCompensationOwnership
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 213.0k
Tran Nguyen
CFO & Chief Strategy Officer11.7yrsUS$2.70m0.0060%
$ 53.3k
Brandon Smith
Chief Operating Officer3.1yrsUS$2.63m0%
$ 0
Carol Karp
Chief Regulatory Officer7.9yrsUS$2.57m0%
$ 0
Karin Walker
Chief Accounting Officer & Controller11.5yrsno datano data
Wagner Zago
Chief Scientific Officer7.4yrsUS$3.34mno data
Mark Johnson
Vice President of Investor Relationsno datano datano data
Michael Malecek
Chief Legal Officerno dataUS$1.18mno data
David Ford
Chief People Officerless than a yearno datano data
Chad Swanson
Chief Development Officerless than a yearno datano data
Yvonne Tchrakian
Company Secretaryno datano datano data

7.7yrs

Average Tenure

55yo

Average Age

Experienced Management: PRTA's management team is seasoned and experienced (7.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gene Kinney
President8.2yrsUS$7.04m0.024%
$ 213.0k
Helen Kim
Independent Director2.3yrsUS$896.63k0%
$ 0
Richard Collier
Independent Director11.9yrsUS$912.48k0.0023%
$ 20.3k
Daniel Welch
Independent Chairmanless than a yearno datano data
Lars Ekman
Independent Chair Emeritusless than a yearUS$923.48k0.00045%
$ 4.0k
Shane Cooke
Independent Director11.9yrsUS$917.26k0%
$ 0
Dennis Selkoe
Independent Director11.3yrsUS$901.73k0.0078%
$ 70.0k
Paula Cobb
Independent Director5.3yrsUS$908.48k0%
$ 0
Oleg Nodelman
Independent Director4.9yrsno datano data
William Dunn
Independent Director1.5yrsUS$1.70mno data

5.1yrs

Average Tenure

62yo

Average Age

Experienced Board: PRTA's board of directors are considered experienced (5.1 years average tenure).